Clear Search sequence regions
Bookmark Forward

QuickView for Risedronate (compound)


DrugBank
Identification
Name: risedronate
Name (isomeric): DB00884
Drug Type: small molecule
Synonyms:
Risedronic acid; NE-58095; Risedronate sodium
Brand: Benet, Actonel 150, Actonel
Brand name mixture: Actonel with Calcium (Procter & Gamble)(risedronate sodium + calcium carbonate), Actonal Plus Calcium (Warner Chilcott)(risedronate sodium hemi-pentahydrate + calcium carbonate)
Category: Antihypocalcemic Agents, Bisphosphonates, Calcium Channel Blockers, Bone Density Conservation Agents, Antiresorptives
CAS number: 105462-24-6
Pharmacology
Indication: For the treatment of Paget's disease of the bone (osteitis deformans), postmenopausal and glucocorticoid-induced osteoporosis
Pharmacology: Risedronate is a pyridinyl bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism and is indicated for the treatment and prevention of osteoporosis in postmenopausal women.
Mechanism of Action:
The action of risedronate on bone tissue is based partly on its affinity for hydroxyapatite, which is part of the mineral matrix of bone. Risedronate also targets farnesyl pyrophosphate (FPP) synthase. Nitrogen-containing bisphosphonates (such as pamidronate, alendronate, risedronate, ibandronate and zoledronate) appear to act as analogues of isopr...
show more »
Absorption: Rapid absorption (~1 hr) after an oral dose, occurs throughout the upper gastrointestinal tract
Protein binding: ~24%
Biotransformation: No evidence found for metabolization of risedronate in humans or mammals
Route of elimination: Risedronate is excreted unchanged primarily via the kidney. Insignificant amounts (<0.1% of intravenous dose) of drug are excreted in the bile in rats.
Half Life: 1.5 hours
Clearance: 122 mL/min 73 mL/min [osteopenic postmenopausal women]
Toxicity: Side effects include abdominal pain, anxiety, back pain, belching, bladder irritation, bone disorders and pain, bronchitis, bursitis, cataracts, chest pain, colitis, constipation, depression, diarrhea, difficulty breathing, dizziness, dry eyes, eye infection, flu-like symptoms, gas, headache, high blood pressure, infection, insomnia, itching, joint disorders and pain, leg cramps, muscle pain, muscle weakness, nausea, neck pain, nerve pain, pain, pneumonia, rash, ringing in ears, sinus problems, sore throat, stomach bleeding, stuffy or runny nose, swelling, tendon problems, tumor, ulcers, urinary tract infection, vertigo, vision problems, and weakness.
Affected organisms: Humans and other mammals
Interactions
Drug interaction:
MagnesiumFormation of non-absorbable complexes
Iron DextranFormation of non-absorbable complexes
Calcium AcetateCalcium Salts may decrease the serum concentration of Bisphosphonate Derivatives such as risedronate. Avoid administration of oral calcium supplements within or 30 minutes after risedronate.
Calcium ChlorideCalcium salts may decrease the serum concentration of bisphosphonate derivatives. Avoid administration of oral calcium supplements within 30 minutes after alendronate/risedronate.
CalciumFormation of non-absorbable complexes

Targets